Literature DB >> 2656044

Protein binding drug displacement interactions fact or fiction?

J J MacKichan1.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2656044     DOI： 10.2165/00003088-198916020-00001

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  59 in total

Review 1.  Carbamazepine drug interactions.

Authors:  A M Baciewicz
Journal:  Ther Drug Monit       Date:  1986       Impact factor: 3.681

2.  The effect of organic acids on renal clearance of methotrexate in man.

Authors:  D G Liegler; E S Henderson; M A Hahn; V T Oliverio
Journal:  Clin Pharmacol Ther       Date:  1969 Nov-Dec       Impact factor: 6.875

3.  Kinetics of drug displacement interactions.

Authors:  L J Aarons; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1981-04

4.  Administration of heparin causes in vitro release of non-esterified fatty acids in human plasma.

Authors:  K M Giacomini; S E Swezey; J C Giacomini; T F Blaschke
Journal:  Life Sci       Date:  1980-09-01       Impact factor: 5.037

5.  Clofibrate displaces warfarin from plasma proteins in man: an example of a pure displacement interaction.

Authors:  T D Bjornsson; P J Meffin; S Swezey; T F Blaschke
Journal:  J Pharmacol Exp Ther       Date:  1979-09       Impact factor: 4.030

6.  Effect of valproate on free plasma phenytoin concentrations.

Authors:  L M Tsanaclis; J Allen; E Perucca; P A Routledge; A Richens
Journal:  Br J Clin Pharmacol       Date:  1984-07       Impact factor: 4.335

7.  The artifactual nature of heparin-induced drug protein-binding alterations.

Authors:  J E Brown; B B Kitchell; T D Bjornsson; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1981-11       Impact factor: 6.875

8.  Phenytoin-valproate interaction: importance of saliva monitoring in epilepsy.

Authors:  C Knott; A Hamshaw-Thomas; F Reynolds
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-02

9.  Phenytoin-salicylate interaction.

Authors:  R F Leonard; P J Knott; G O Rankin; D S Robinson; D E Melnick
Journal:  Clin Pharmacol Ther       Date:  1981-01       Impact factor: 6.875

10.  Interaction between phenytoin and valproic acid: plasma protein binding and metabolic effects.

Authors:  E Perucca; S Hebdige; G M Frigo; G Gatti; S Lecchini; A Crema
Journal:  Clin Pharmacol Ther       Date:  1980-12       Impact factor: 6.875
View more
  17 in total

1.  Single and multiple dose pharmacokinetics of nelfinavir and CYP2C19 activity in human immunodeficiency virus-infected patients with chronic liver disease.

Authors:  Y Khaliq; K Gallicano; I Seguin; K Fyke; G Carignan; D Bulman; A Badley; D W Cameron
Journal:  Br J Clin Pharmacol       Date:  2000-08       Impact factor: 4.335

Review 2.  The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery.

Authors:  Dennis A Smith; Li Di; Edward H Kerns
Journal:  Nat Rev Drug Discov       Date:  2010-12       Impact factor: 84.694

Review 3.  What is the true clinical significance of plasma protein binding displacement interactions?

Authors:  L N Sansom; A M Evans
Journal:  Drug Saf       Date:  1995-04       Impact factor: 5.606

Review 4.  Clinical significance of pharmacokinetic models of hepatic elimination.

Authors:  D J Morgan; R A Smallwood
Journal:  Clin Pharmacokinet       Date:  1990-01       Impact factor: 6.447

Review 5.  Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

6.  In vitro changes in the proportion of protein-unbound-free propofol induced by valproate.

Authors:  Minako Ishii-Maruhama; Hitoshi Higuchi; Mai Nakanou; Yuka Honda-Wakasugi; Akiko Yabuki-Kawase; Shigeru Maeda; Takuya Miyawaki
Journal:  J Anesth       Date:  2018-07-30       Impact factor: 2.078

Review 7.  Important drug interactions in dermatology.

Authors:  T C Roos; H F Merk
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

Review 8.  Choice and use of newer anticonvulsant drugs in older patients.

Authors:  L J Willmore
Journal:  Drugs Aging       Date:  2000-12       Impact factor: 3.923

9.  Prinomide tromethamine pharmacokinetics: mutually dependent saturable and competitive protein binding between prinomide and its own metabolite.

Authors:  G M Kochak; S Pai; R Iannucci; F Honc; D Kachmar; P Perrino; H Egger
Journal:  Pharm Res       Date:  1993-01       Impact factor: 4.200

Review 10.  Pharmacokinetic optimisation of oral hypoglycaemic therapy.

Authors:  P Marchetti; R Giannarelli; A di Carlo; R Navalesi
Journal:  Clin Pharmacokinet       Date:  1991-10       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.